ALPS Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Buy |
1,130
+14
| +1% | +$4.02K | ﹤0.01% | 909 |
|
|
2025
Q1 | $344K | Buy |
1,116
+105
| +10% | +$32.4K | ﹤0.01% | 817 |
|
|
2024
Q4 | $357K | Sell |
1,011
-5
| -0.5% | -$1.76K | ﹤0.01% | 777 |
|
|
2024
Q3 | $364K | Sell |
1,016
-364
| -26% | -$130K | ﹤0.01% | 783 |
|
|
2024
Q2 | $440K | Sell |
1,380
-17
| -1% | -$5.42K | ﹤0.01% | 607 |
|
|
2024
Q1 | $321K | Sell |
1,397
-48
| -3% | -$11K | ﹤0.01% | 892 |
|
|
2023
Q4 | $318K | Sell |
1,445
-50
| -3% | -$11K | ﹤0.01% | 823 |
|
|
2023
Q3 | $338K | Buy |
1,495
+105
| +8% | +$23.7K | ﹤0.01% | 701 |
|
|
2023
Q2 | $307K | Buy |
1,390
+10
| +0.7% | +$2.21K | ﹤0.01% | 855 |
|
|
2023
Q1 | $309K | Buy |
+1,380
| New | +$309K | ﹤0.01% | 845 |
|
|
2021
Q3 | – | Sell |
-2,035
| Closed | -$365K | – | 1029 |
|
|
2021
Q2 | $365K | Hold |
2,035
| – | – | ﹤0.01% | 645 |
|
|
2021
Q1 | $340K | Buy |
+2,035
| New | +$340K | ﹤0.01% | 651 |
|
|
2020
Q4 | – | Sell |
-56,636
| Closed | -$5.72M | – | 880 |
|
|
2020
Q3 | $5.72M | Sell |
56,636
-3,400
| -6% | -$343K | 0.08% | 150 |
|
|
2020
Q2 | $7.26M | Sell |
60,036
-17,775
| -23% | -$2.15M | 0.1% | 132 |
|
|
2020
Q1 | $7.38M | Sell |
77,811
-10,569
| -12% | -$1M | 0.11% | 124 |
|
|
2019
Q4 | $7.79M | Buy |
88,380
+988
| +1% | +$87K | 0.06% | 130 |
|
|
2019
Q3 | $6.97M | Sell |
87,392
-4,010
| -4% | -$320K | 0.05% | 128 |
|
|
2019
Q2 | $7.14M | Buy |
91,402
+15,103
| +20% | +$1.18M | 0.05% | 137 |
|
|
2019
Q1 | $8.96M | Sell |
76,299
-782
| -1% | -$91.8K | 0.06% | 126 |
|
|
2018
Q4 | $8.39M | Sell |
77,081
-3,822
| -5% | -$416K | 0.07% | 123 |
|
|
2018
Q3 | $10.3M | Buy |
80,903
+18,015
| +29% | +$2.3M | 0.07% | 120 |
|
|
2018
Q2 | $7.12M | Buy |
+62,888
| New | +$7.12M | 0.05% | 138 |
|
|
2017
Q3 | – | Sell |
-3,827
| Closed | -$496K | – | 875 |
|
|
2017
Q2 | $496K | Buy |
3,827
+86
| +2% | +$11.1K | ﹤0.01% | 512 |
|
|
2017
Q1 | $506K | Buy |
3,741
+350
| +10% | +$47.3K | ﹤0.01% | 405 |
|
|
2016
Q4 | $486K | Sell |
3,391
-33
| -1% | -$4.73K | ﹤0.01% | 429 |
|
|
2016
Q3 | $404K | Buy |
3,424
+83
| +2% | +$9.79K | ﹤0.01% | 596 |
|
|
2016
Q2 | $354K | Sell |
3,341
-208
| -6% | -$22K | ﹤0.01% | 541 |
|
|
2016
Q1 | $395K | Buy |
+3,549
| New | +$395K | ﹤0.01% | 564 |
|
|
2015
Q3 | – | Sell |
-2,977
| Closed | -$518K | – | 773 |
|
|
2015
Q2 | $518K | Buy |
2,977
+46
| +2% | +$8K | ﹤0.01% | 465 |
|
|
2015
Q1 | $505K | Sell |
2,931
-1,129
| -28% | -$195K | ﹤0.01% | 563 |
|
|
2014
Q4 | $526K | Sell |
4,060
-540
| -12% | -$70K | ﹤0.01% | 433 |
|
|
2014
Q3 | $592K | Buy |
+4,600
| New | +$592K | ﹤0.01% | 314 |
|
|
2014
Q1 | – | Sell |
-6,222
| Closed | -$639K | – | 674 |
|
|
2013
Q4 | $639K | Buy |
6,222
+3,010
| +94% | +$309K | 0.01% | 179 |
|
|
2013
Q3 | $253K | Buy |
+3,212
| New | +$253K | ﹤0.01% | 372 |
|